To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful., changes federal law or congressional policy affecting transportation operators and travelers. The main policy domain is Transportation, Trade, Healthcare.
Who Benefits and How
transportation operators and travelers may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, transportation operators and travelers may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H7D85E7ADC62A441E9B0EB59A6E4E915D: 1. Short title This Act may be cited as the Fentanyl Safe Testing and Overdose Prevention Act.
- Section idebde201ef00749be8fc790d06f844ea6: 2. Clarification Section 422 of the Controlled Substances Act (21 U.S.C. 863) is amended by adding at the end the following: (g)ClarificationThis section does...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful., changes federal law or congressional policy affecting transportation operators and travelers.
Key Policy Areas
Transportation, Trade, Healthcare
Primary Purpose
This bill, To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful., changes federal law or congressional policy affecting transportation operators and travelers.
Policy Domains
Whole bill
Identified Gains
- transportation operators and travelers
Identified Costs
- federal implementing agencies
- transportation operators and travelers
Sponsors
Legislative Progress
IntroducedMr. Cornyn (for himself, Mr. Coons, Mr. Cotton, Ms. Klobuchar, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology